64 filings
Page 2 of 4
6-K
8xw9f8 a2p5tv8
29 Jun 23
Current report (foreign)
4:01pm
6-K
6h9q tg1t414wd
8 Jun 23
Current report (foreign)
4:30pm
6-K
wcw3f
7 Jun 23
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of
4:33pm
6-K
958rmolxb0 vy6
18 May 23
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3
9:10am
6-K
poan2
15 May 23
Condensed Financial Statements
4:51pm
6-K/A
n22yeptr4 gfgia96
4 May 23
Annual General Meeting of Shareholders to Be
8:19am
6-K
8nidj6
3 May 23
Annual General Meeting of Shareholders to Be
5:25pm
6-K
jxbbm
1 May 23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
8:41am
6-K
2i908uf6t1bvudo6
28 Mar 23
PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery
9:16am
6-K
4qvr09d
16 Mar 23
Current report (foreign)
8:09am
6-K
r8f lemy9sy3tyeqckw
14 Mar 23
PainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery
8:05am
6-K
4ld3fcnkqmtu28g
7 Feb 23
Current report (foreign)
4:11pm
6-K
dj64a2nd
29 Dec 22
Current report (foreign)
4:31pm
6-K
iix8uz
25 Nov 22
Annual General Meeting of Shareholders to Be
4:30pm
6-K
t8hsl7aftayw qrkkh8
15 Nov 22
PainReform Provides Business Update for the Third Quarter of 2022
8:47am
6-K
1stonwkq2u6rpo qf
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
qz3ju1jcmm kn
8 Nov 22
PainReform Provides Further Update on Manufacturing of PRF-110
8:42am
6-K
9yxx3bbkfdg14g6t8i4
4 Oct 22
PainReform Provides PRF-110 Manufacturing Update
10:21am
6-K
zzmq7naz63ioxadi
16 Aug 22
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
8:08am
6-K
hch 9lyue
15 Aug 22
Current report (foreign)
6:16pm